Ronald Goldwater

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

Richard E. Nettles, Min Gao, Marc Bifano et al. · Hepatology · 2010 · 177 citations · Full text

Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study

Marek Malík, E. Marcel van Gelderen, J H Lee et al. · Clinical Pharmacology & Therapeutics · 2012 · 147 citations

AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease

Gvido Cebers, Robert Alexander, Samantha Budd Haeberlein et al. · Journal of Alzheimer s Disease · 2016 · 86 citations

Healthy Subjects, Neurochemical Biomarkers, Pharmacotherapy +18

A Phase 1, Randomized Ascending Single-Dose Study of Antagonist Anti-Human CD40 ASKP1240 in Healthy Subjects

Ronald Goldwater, James J. Keirns, Paul Blahunka et al. · American Journal of Transplantation · 2013 · 68 citations · Full text

Healthy Subjects, Immunology, Pharmacotherapy +19

Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C

C Pasquinelli, Fiona McPhee, Timothy Eley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 51 citations · Full text

Hepatology, Hepatitis C, Healthy Subjects +15